- Home
- JHG vs ELAN Comparison
JHG vs ELAN Comparison
Compare JHG & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHG
- ELAN
- Stock Information
- Founded
- JHG 1934
- ELAN 1954
- Country
- JHG United Kingdom
- ELAN United States
- Employees
- JHG N/A
- ELAN N/A
- Industry
- JHG Investment Managers
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- JHG Finance
- ELAN Health Care
- Exchange
- JHG Nasdaq
- ELAN Nasdaq
- Market Cap
- JHG 5.7B
- ELAN 6.0B
- IPO Year
- JHG N/A
- ELAN 2018
- Fundamental
- Price
- JHG $36.64
- ELAN $13.48
- Analyst Decision
- JHG Buy
- ELAN Buy
- Analyst Count
- JHG 11
- ELAN 6
- Target Price
- JHG $41.27
- ELAN $15.17
- AVG Volume (30 Days)
- JHG 1.2M
- ELAN 5.8M
- Earning Date
- JHG 07-31-2025
- ELAN 08-07-2025
- Dividend Yield
- JHG 4.36%
- ELAN N/A
- EPS Growth
- JHG N/A
- ELAN N/A
- EPS
- JHG 2.52
- ELAN 0.75
- Revenue
- JHG $2,542,900,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- JHG $3.15
- ELAN $4.28
- Revenue Next Year
- JHG $5.84
- ELAN $4.67
- P/E Ratio
- JHG $14.56
- ELAN $17.93
- Revenue Growth
- JHG 17.85
- ELAN 1.42
- 52 Week Low
- JHG $28.26
- ELAN $8.02
- 52 Week High
- JHG $46.68
- ELAN $18.55
- Technical
- Relative Strength Index (RSI)
- JHG 53.33
- ELAN 56.01
- Support Level
- JHG $36.17
- ELAN $13.32
- Resistance Level
- JHG $37.09
- ELAN $14.15
- Average True Range (ATR)
- JHG 0.63
- ELAN 0.38
- MACD
- JHG -0.07
- ELAN -0.16
- Stochastic Oscillator
- JHG 72.22
- ELAN 27.11
About JHG Janus Henderson Group plc
Janus Henderson Group provides investment management services to retail intermediary (55% of managed assets), self-directed (22%) and institutional (23%) clients. At the end of March 2025, active equities (58%), fixed-income (24%), multiasset (14%) and alternative (4%) investment platforms constituted the company's $373 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (62%), with customers from Europe, the Middle East, Africa, and Latin America (28%) and the Asia-Pacific region (10%) accounting for the remainder.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.